Human Brain and Spinal Cord Tumors: From Bench to Bedside. Volume 2: The Path to Bedside Management
暫譯: 人腦與脊髓腫瘤：從實驗室到臨床。第二卷：臨床管理之路
Rezaei, Nima, Hanaei, Sara
- 出版商: Springer
- 出版日期: 2024-08-03
- 售價: $4,740
- 貴賓價: 9.5 折 $4,503
- 語言: 英文
- 頁數: 739
- 裝訂: Quality Paper - also called trade paper
- ISBN: 3031237072
- ISBN-13: 9783031237072
海外代購書籍(需單獨結帳)
相關主題
商品描述
This book aims to gather the current knowledge regarding different aspects of brain and spinal cord tumors in order to more efficiently help the patients. Brain tumors comprise about 5-9% of all human neoplasms; and the central nervous system (CNS) neoplasms are ranked among the most prevalent neoplasms of childhood as well. The more we know about the nature and characteristic of brain and spinal cord tumors, the more precise decision could be made for each patient, in order to reach the best outcome. While surgical resection, chemotherapy, and radiotherapy have been considered as the standards of care for benign and/or malignant CNS tumors since a long time ago, new therapeutic approaches such as immunotherapy have been recently proposed to be considered for treatment of CNS tumors, especially as in some cases, the tumors might be inoperable or the patient may not benefit from other treatment modalities after several recurrences.
The second volume of the book focuses on clinical aspects of these tumors. Accordingly, the most important brain and spinal cord tumors are specifically discussed in each chapter based on a rational outlining for all chapter in this volume: Background and epidemiology, genetics, immunology and molecular biology, histopathology and morphology, imaging and radiologic features, clinical manifestations, therapeutic approaches, surgical intervention, chemotherapy and radiotherapy, new therapeutic modalities, follow-up, and prognosis. The chapters of this volume discuss the following pathologies of brain and spinal cord tumors: malignant glioma, benign glioma, meningiomas and other meningeal tumors, ependymomas, medulloblastomas, pineal tumors, choroid plexus and ventricular tumors, neuroectodermal tumors of CNS, neuroepithelial tumors of CNS, pituitary gland tumors, craniopharyngioma, schwannomas and nerve-sheet tumors, hemangioblastomas and other vascular originating tumors, brain and spinal tumors of embryonic origin, germ line cell tumors, malignant bone or cartilage-originating tumors of brain and spine, benign bone or cartilage-originating tumors of brain and spine, brain tumors affecting the orbit globe and orbit tumors affecting the brain, CNS lymphomas, metastatic lesions of the brain and spine, malignant spinal tumors, benign spinal tumors, brain and/or spinal cord tumors accompanied with other diseases or syndromes, psychological and psychiatric aspects of brain and spinal cord tumors, a brief explanation on surgical approaches for treatment of different brain tumors. This volume of book is useful for physicians of different specialties, mainly neurosurgeons, neurologists, neuropathologists, and neuroradiologists.商品描述(中文翻譯)
本書旨在彙集有關腦部和脊髓腫瘤不同方面的當前知識，以更有效地幫助患者。腦腫瘤約佔所有人類腫瘤的5-9%；而中樞神經系統（CNS）腫瘤在兒童中也是最常見的腫瘤之一。我們對腦部和脊髓腫瘤的性質和特徵了解得越多，就能為每位患者做出更精確的決策，以達到最佳的治療效果。雖然外科切除、化療和放療長期以來被視為良性和/或惡性CNS腫瘤的標準治療，但最近提出了新的治療方法，如免疫療法，應考慮用於CNS腫瘤的治療，特別是在某些情況下，腫瘤可能無法手術切除，或患者在多次復發後可能無法從其他治療方式中受益。
本書的第二卷專注於這些腫瘤的臨床方面。因此，本卷中的每一章都根據合理的框架具體討論了最重要的腦部和脊髓腫瘤：背景與流行病學、遺傳學、免疫學與分子生物學、組織病理學與形態學、影像學與放射特徵、臨床表現、治療方法、外科介入、化療與放療、新的治療方式、隨訪與預後。本卷的章節討論了以下腦部和脊髓腫瘤的病理：惡性膠質瘤、良性膠質瘤、腦膜瘤及其他腦膜腫瘤、室管膜瘤、小腦母細胞瘤、松果體腫瘤、脈絡叢及腦室腫瘤、中樞神經系統的神經外胚層腫瘤、中樞神經系統的神經上皮腫瘤、腦下垂體腫瘤、顱咽管瘤、施旺細胞瘤及神經鞘腫瘤、血管母細胞瘤及其他血管來源腫瘤、胚胎來源的腦部和脊髓腫瘤、生殖細胞腫瘤、腦部和脊髓的惡性骨或軟骨來源腫瘤、腦部和脊髓的良性骨或軟骨來源腫瘤、影響眼眶的腦腫瘤及影響腦部的眼眶腫瘤、中樞神經系統淋巴瘤、腦部和脊髓的轉移性病變、惡性脊髓腫瘤、良性脊髓腫瘤、伴隨其他疾病或綜合症的腦和/或脊髓腫瘤、腦部和脊髓腫瘤的心理和精神方面、以及對不同腦腫瘤的外科治療方法的簡要說明。本卷對於不同專科的醫生，主要是神經外科醫生、神經科醫生、神經病理學家和神經放射科醫生，具有實用價值。
作者簡介
Dr. Sara Hanaei started medicine at TUMS in 2010 and started a master of public health (MPH) in 2014. She graduated with MD-MPH in 2018. She also received TUMS Research Diploma (TUMS-RD) in a 2-year study period from 2013-2015. She was a research assistant at Research Center for Immunodeficiencies (RCID) from 2018-2021 and further continued neurosurgery as a clinical specialty at TUMS in 2021. She has experience in teaching research skills to students.
Medical research was one of her greatest interests since the beginning of her academic education, especially in the fields of Neurosurgery and Immunology, therefore, she started research in those fields. Over the past decade, she contributed to different research projects, books, and other research activities including instructing research workshops in statistics, systematic reviews, and meta-analysis. She got involved in executive tasks and developed some executive skills through membership in the Universal Scientific Education and Research Network (USERN), where she experienced organizing scientific events, congresses, festivals, scoring, rankings, etc.作者簡介(中文翻譯)
尼瑪·雷扎伊教授（Nima Rezaei）於德黑蘭醫科大學獲得醫學學位（MD），隨後在英國謝菲爾德大學獲得分子與遺傳醫學碩士（MSc）及臨床免疫學與人類遺傳學博士（PhD）。他還在紐卡索綜合醫院完成了兒科臨床免疫學和骨髓移植的短期研究獎學金。雷扎伊教授目前是德黑蘭醫科大學醫學院的免疫學全職教授及研究與技術副院長，並且是免疫缺陷研究中心的共同創辦人及負責人。他也是全球科學教育與研究網絡（USERN）的創始會長。雷扎伊教授已經擔任超過100個研究項目的主任，並設計及參與了多個國際合作項目。他是超過40本國際期刊的編輯、編輯助理或編輯委員會成員，編輯了超過50本國際書籍，並在會議/研討會上發表了超過500場講座/海報，已在國際期刊上發表超過1,100篇科學論文。
薩拉·哈納伊博士（Sara Hanaei）於2010年在德黑蘭醫科大學（TUMS）開始醫學學習，並於2014年開始公共衛生碩士（MPH）課程。她於2018年獲得MD-MPH學位。她還在2013至2015年的兩年學習期間獲得TUMS研究文憑（TUMS-RD）。她於2018至2021年在免疫缺陷研究中心（RCID）擔任研究助理，並於2021年繼續在TUMS進行神經外科的臨床專業學習。她在教授學生研究技能方面有經驗。
醫學研究自她學術教育開始以來就是她最大的興趣之一，特別是在神經外科和免疫學領域，因此她開始在這些領域進行研究。在過去的十年中，她參與了不同的研究項目、書籍及其他研究活動，包括教授統計學、系統性回顧和元分析的研究工作坊。她通過成為全球科學教育與研究網絡（USERN）的成員，參與了執行任務並發展了一些執行技能，並在組織科學活動、會議、節慶、評分、排名等方面獲得了經驗。
